449 related articles for article (PubMed ID: 35643089)
1. Immunoglobulin-free strategy to prevent HBV mother-to-child transmission in Cambodia (TA-PROHM): a single-arm, multicentre, phase 4 trial.
Segeral O; Dim B; Durier C; Nhoueng S; Chhim K; Sovann S; Yom S; Vong C; Yin S; Ros B; Ky V; Pech S; Nem B; Hout K; Guillebaud J; Ear E; Caroupaye-Caroupin L; Rekacewicz C; Fernandez L; Laurent D; Yay C; Kim R; Meyer L; Chhun S;
Lancet Infect Dis; 2022 Aug; 22(8):1181-1190. PubMed ID: 35643089
[TBL] [Abstract][Full Text] [Related]
2. Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen.
Jourdain G; Ngo-Giang-Huong N; Cressey TR; Hua L; Harrison L; Tierney C; Salvadori N; Decker L; Traisathit P; Sirirungsi W; Khamduang W; Bowonwatanuwong C; Puthanakit T; Siberry GK; Watts DH; Murphy TV; Achalapong J; Hongsiriwon S; Klinbuayaem V; Thongsawat S; Chung RT; Pol S; Chotivanich N
BMC Infect Dis; 2016 Aug; 16():393. PubMed ID: 27506549
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B immunoglobulin during pregnancy for prevention of mother-to-child transmission of hepatitis B virus.
Eke AC; Eleje GU; Eke UA; Xia Y; Liu J
Cochrane Database Syst Rev; 2017 Feb; 2(2):CD008545. PubMed ID: 28188612
[TBL] [Abstract][Full Text] [Related]
4. Arresting vertical transmission of hepatitis B virus (AVERT-HBV) in pregnant women and their neonates in the Democratic Republic of the Congo: a feasibility study.
Thompson P; Morgan CE; Ngimbi P; Mwandagalirwa K; Ravelomanana NLR; Tabala M; Fathy M; Kawende B; Muwonga J; Misingi P; Mbendi C; Luhata C; Jhaveri R; Cloherty G; Kaba D; Yotebieng M; Parr JB
Lancet Glob Health; 2021 Nov; 9(11):e1600-e1609. PubMed ID: 34416175
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of tenofovir prophylaxis during pregnancy for the elimination of mother-to-child transmission of the hepatitis B virus: real-world analysis from Thailand.
Janekrongtham C; Punsuwan N; Thitichai P; Lertpiriyasuwat C; Pan-Ngum W; Poovorawan K; Jantarapakde J; Tangkijvanich P
BMJ Open; 2023 Jul; 13(7):e067275. PubMed ID: 37474179
[TBL] [Abstract][Full Text] [Related]
6. Prospective cohort study of prevention of mother to child transmission of hepatitis B infection and 9 months follow-up of hepatitis B-exposed infants at Ile-Ife, Nigeria.
Ndububa D; Kuti O; Awowole I; Adekanle O; Ijarotimi O; Makinde O; Adeyemi A; Anyabolu C; Ijadunola M
BMJ Open; 2022 Nov; 12(11):e063482. PubMed ID: 36351715
[TBL] [Abstract][Full Text] [Related]
7. Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B.
Jourdain G; Ngo-Giang-Huong N; Harrison L; Decker L; Khamduang W; Tierney C; Salvadori N; Cressey TR; Sirirungsi W; Achalapong J; Yuthavisuthi P; Kanjanavikai P; Na Ayudhaya OP; Siriwachirachai T; Prommas S; Sabsanong P; Limtrakul A; Varadisai S; Putiyanun C; Suriyachai P; Liampongsabuddhi P; Sangsawang S; Matanasarawut W; Buranabanjasatean S; Puernngooluerm P; Bowonwatanuwong C; Puthanakit T; Klinbuayaem V; Thongsawat S; Thanprasertsuk S; Siberry GK; Watts DH; Chakhtoura N; Murphy TV; Nelson NP; Chung RT; Pol S; Chotivanich N
N Engl J Med; 2018 Mar; 378(10):911-923. PubMed ID: 29514030
[TBL] [Abstract][Full Text] [Related]
8. Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial.
Buti M; Gane E; Seto WK; Chan HL; Chuang WL; Stepanova T; Hui AJ; Lim YS; Mehta R; Janssen HL; Acharya SK; Flaherty JF; Massetto B; Cathcart AL; Kim K; Gaggar A; Subramanian GM; McHutchison JG; Pan CQ; Brunetto M; Izumi N; Marcellin P;
Lancet Gastroenterol Hepatol; 2016 Nov; 1(3):196-206. PubMed ID: 28404092
[TBL] [Abstract][Full Text] [Related]
9. Tenofovir alafenamide or tenofovir disoproxil fumarate in pregnancy to prevent HBV transmission: Maternal ALT trajectory and infant outcomes.
Chen HL; Lee CN; Chang CH; Lai MW; Tsai MC; Mu SC; Liu CJ; Shih JC; Wen WH; Hu RT; Huang CP; Hu KC; Chen CP; Lee CL; Chien RN; Chang KC; Hsu HY; Lee CC; Ni YH; Chang MH
Liver Int; 2024 Jun; 44(6):1422-1434. PubMed ID: 38456620
[TBL] [Abstract][Full Text] [Related]
10. [Clinical study on blocking mother-to-child transmission of hepatitis B virus with high viral load and HBeAg positivity during pregnancy in Guizhou province].
Zhang BF; Cheng ML; Zhang Q; Zhao XK; Yu L; Yang J; Deng KS; Zhang LS; Wang J; Hu YX
Zhonghua Gan Zang Bing Za Zhi; 2018 Dec; 26(12):945-950. PubMed ID: 30669789
[No Abstract] [Full Text] [Related]
11. Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load.
Pan CQ; Duan Z; Dai E; Zhang S; Han G; Wang Y; Zhang H; Zou H; Zhu B; Zhao W; Jiang H;
N Engl J Med; 2016 Jun; 374(24):2324-34. PubMed ID: 27305192
[TBL] [Abstract][Full Text] [Related]
12. Real-world study of tenofovir disoproxil fumarate to prevent hepatitis B transmission in mothers with high viral load.
Wang M; Bian Q; Zhu Y; Pang Q; Chang L; Li R; Tiongson BC; Zhang H; Pan CQ
Aliment Pharmacol Ther; 2019 Jan; 49(2):211-217. PubMed ID: 30506691
[TBL] [Abstract][Full Text] [Related]
13. Is the use of Tenofovir Dipivoxil fumarate effective and safe in preventing vertical transmission in pregnant women with chronic HBV with high viral load?
Aladag H; Aladag M
Eur Rev Med Pharmacol Sci; 2023 Mar; 27(5):2091-2098. PubMed ID: 36930508
[TBL] [Abstract][Full Text] [Related]
14. Tenofovir disoproxil fumarate in pregnancy for prevention of mother to child transmission of hepatitis B in a rural setting on the Thailand-Myanmar border: a cost-effectiveness analysis.
Bierhoff M; Angkurawaranon C; Rijken MJ; Sriprawa K; Kobphan P; Nosten FN; van Vugt M; McGready R; Devine A
BMC Pregnancy Childbirth; 2021 Feb; 21(1):157. PubMed ID: 33618698
[TBL] [Abstract][Full Text] [Related]
15. Tenofovir for prevention of mother to child transmission of hepatitis B in migrant women in a resource-limited setting on the Thailand-Myanmar border: a commentary on challenges of implementation.
Bierhoff M; Rijken MJ; Yotyingaphiram W; Pimanpanarak M; van Vugt M; Angkurawaranon C; Nosten F; Ehrhardt S; Thio CL; McGready R
Int J Equity Health; 2020 Sep; 19(1):156. PubMed ID: 32912268
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of antiviral prophylaxis during pregnancy to prevent mother-to-child transmission of hepatitis B virus: a systematic review and meta-analysis.
Funk AL; Lu Y; Yoshida K; Zhao T; Boucheron P; van Holten J; Chou R; Bulterys M; Shimakawa Y
Lancet Infect Dis; 2021 Jan; 21(1):70-84. PubMed ID: 32805200
[TBL] [Abstract][Full Text] [Related]
17. Association of vitamin D and polymorphisms of its receptor with antiviral therapy in pregnant women with hepatitis B.
Wang R; Zhu X; Zhang X; Liu H; Ji YL; Chen YH
World J Gastroenterol; 2023 May; 29(19):3003-3012. PubMed ID: 37274802
[TBL] [Abstract][Full Text] [Related]
18. Antivirals for prevention of hepatitis B virus mother-to-child transmission in human immunodeficiency virus positive pregnant women co-infected with hepatitis B virus.
Ugwu EO; Eleje GU; Ugwu AO; Nwagha UI; Ikechebelu JI; Umeh UA; Okafor HU
Cochrane Database Syst Rev; 2023 Jun; 6(6):CD013653. PubMed ID: 37306558
[TBL] [Abstract][Full Text] [Related]
19. Effects of hepatitis B immunization on prevention of mother-to-infant transmission of hepatitis B virus and on the immune response of infants towards hepatitis B vaccine.
Zhang L; Gui XE; Teter C; Zhong H; Pang Z; Ding L; Li F; Zhou Y; Zhang L
Vaccine; 2014 Oct; 32(46):6091-7. PubMed ID: 25240752
[TBL] [Abstract][Full Text] [Related]
20. Kinetics of hepatitis B surface antigen in pregnant women with and without tenofovir disoproxil fumarate.
Chang HL; Wen WH; Lee CN; Chiu YE; Liu CJ; Chang MH; Lin LH; Chen HL
J Viral Hepat; 2022 Feb; 29(2):107-114. PubMed ID: 34724288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]